Results for: glaxosmithkline

EU puts conditions on deals involving Novartis, GSK

Gates sees 'miracle' tools for AIDS by 2030 in vaccine and drugs

EU clears plans by drugmakers GSK and Novartis to trade assets

US: Long-awaited Ebola vaccine study coming soon in Liberia

Pfizer $33 Billion Question Remains After Teva, Actavis Feelers

Ebola vaccine is safe, researchers say

Ebola vaccine shipped to Liberia

Novartis Sees Sales Gain Resuming After Earnings Beat Estimates

Top-Selling Vaccine Made Cheap Shows Challenge to Merck: Health

FDA panel backs inhaler drug for lung disease

Glaxo, Theravance rise on FDA review of lung drug

Ky. attorney general sues GlaxoSmithKline

Drugmakers, Interpol ramp up fight against fakes

Europe dents Glaxo's Q4 profits

Biggest civil settlements for Justice Dept.

GSK cancer vaccine misses target in melanoma trial

Analysis - Bribery scandal dents Big Pharma sales in China, GSK hardest hit